Skip to main content
. 2020 Apr 28;51(12):2023–2033. doi: 10.1017/S0033291720000781

Table 2.

Treatment outcome mean scores, by group

IbET (n = 140) CTRL (n = 140) WL (n = 31)
Variable m s.d. m s.d. m s.d.
PSWQ
Pre-treatment 65.46 6.93 65.20 7.54 66.74 6.33
Post-treatment 52.99 11.49 55.93 10.71 65.00 8.45
4 FUP 50.92 11.26 52.48 10.91
12 FUP 50.55 10.96 52.61 11.48
CAQ
Pre-treatment 68.85 20.02 68.04 19.97 68.77 17.87
Post-treatment 59.19 18.88 64.41 20.50 70.90 21.12
4 FUP 53.78 18.81 53.94 19.25
12 FUP 54.16 17.11 57.91 21.70
MADRS-S
Pre-treatment 14.76 6.50 14.33 6.30 16.03 6.00
Post-treatment 10.30 6.37 10.89 7.22 16.23 6.86
4 FUP 9.75 6.66 9.39 6.08
12 FUP 9.68 6.13 10.29 7.13
IUS
Pre-treatment 77.38 21.75 75.48 19.93 77.55 20.03
Post-treatment 63.22 20.60 66.12 22.22 76.57 21.55
4 FUP 61.16 19.88 61.16 21.61
12 FUP 59.19 20.41 60.75 21.75
BBQ
Pre-treatment 45.92 20.57 43.81 21.71 42.42 18.59
Post-treatment 54.17 20.40 49.84 21.61 43.07 20.58
4 FUP 54.14 22.71 53.47 23.02
12 FUP 53.43 21.43 50.98 22.54

IbET, internet-based extinction therapy; CTRL, control condition (active comparator); WL, waiting-list; PSWQ, Penn State Worry Questionnaire; CAQ, Cognitive Avoidance Questionnaire; MADRS-S, Montgomery Asberg Depression Rating Scale – Self report; IUS, Intolerance of Uncertainty Scale; BBQ, Brunnsviken Brief Quality of life Questionnaire; 4 FUP, 4-month follow-up; 12 FUP, 12-month follow-up.